SHIRE 465 50 mg (Mydayis 50 mg)
Generic Name: amphetamine/dextroamphetamine
Pill with imprint SHIRE 465 50 mg is Purple / White, Capsule-shape and has been identified as Mydayis 50 mg. It is supplied by Shire US, Inc..
Mydayis is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Mydayis 50 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for SHIRE 465 50 mg
Mydayis
- Generic Name
- amphetamine/dextroamphetamine
- Imprint
- SHIRE 465 50 mg
- Strength
- 50 mg
- Color
- Purple / White
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Shire US, Inc.
- National Drug Code (NDC)
- 54092-0477
- Inactive Ingredients
-
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
sucrose,
magnesium silicate,
triethyl citrate,
D&C Red No. 28,
D&C Red No. 33,
titanium dioxide,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
More about Mydayis (amphetamine / dextroamphetamine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 113 Reviews
- Drug class: CNS stimulants
- FDA Alerts (3)
- FDA Approval History
Consumer resources
- Other brands
- Adderall, Adderall XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.